DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANDROGEL

« Back to Dashboard

Clinical Trials for Androgel

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00112151	TEAM: Testosterone Supplementation and Exercise in Elderly Men	Completed	National Institute on Aging (NIA)	Phase 2	2005-01-01	The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00112151	TEAM: Testosterone Supplementation and Exercise in Elderly Men	Completed	University of Colorado, Denver	Phase 2	2005-01-01	The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00114114	Dose-Response of Gonadal Steroids and Bone Turnover in Men	Recruiting	AbbVie	N/A	2004-09-01	The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114	Dose-Response of Gonadal Steroids and Bone Turnover in Men	Recruiting	AstraZeneca	N/A	2004-09-01	The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
NCT00114114	Dose-Response of Gonadal Steroids and Bone Turnover in Men	Recruiting	National Institute on Aging (NIA)	N/A	2004-09-01	The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.

Clinical Trial Conditions for Androgel

Condition Name

Condition Name for Androgel
Intervention	Trials
Hypogonadism	9
Secondary Hypogonadism	4
Healthy	3
Prostate Cancer	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Androgel
Intervention	Trials
Hypogonadism	19
Diabetes Mellitus	4
Prostatic Neoplasms	3
Diabetes Mellitus, Type 2	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Androgel

Trials by Country

Trials by Country for Androgel
Location	Trials
United States	104
Canada	7
Israel	2
Netherlands	2
Germany	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Androgel
Location	Trials
New York	11
Texas	10
California	8
Washington	8
Florida	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Androgel

Clinical Trial Phase

Clinical Trial Phase for Androgel
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	9
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Androgel
Clinical Trial Phase	Trials
Completed	22
Not yet recruiting	8
Recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Androgel

Sponsor Name

Sponsor Name for Androgel
Sponsor	Trials
Solvay Pharmaceuticals	9
Repros Therapeutics Inc.	4
University of Washington	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Androgel
Sponsor	Trials
Other	31
Industry	25
NIH	6

Export unavailable in trial.
Subscribe for complete access.